[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100563835":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":28,"centralContacts":32,"locations":42,"responsibleParty":65,"collaborators":67,"id":71,"slug":72,"hasResults":73,"nctId":74,"briefTitle":75,"officialTitle":75,"acronym":12,"eligibilityCriteria":76,"healthyVolunteers":73,"sex":77,"minAge":78,"maxAge":79,"enrollmentInfo":80,"targetDuration":12,"studyType":83,"phases":84,"briefSummary":87,"conditions":88,"keywords":91,"overallStatus":45,"whyStopped":12,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":105},{"fullName":5,"class":6},"University of California, Davis","OTHER",[8,13],{"label":9,"type":10,"description":11,"interventionNames":12},"Standard of Care Medications for Headache","NO_INTERVENTION","Control arm participants will receive standard of care medications, as defined in a headache protocol, to treat subarachnoid associated headache.",null,{"label":14,"type":15,"description":16,"interventionNames":17},"Transnasal SPG Block and Standard of Care Medications","EXPERIMENTAL","Intervention arm participants will receive standard of care medications, as defined in a headache protocol, with the addition of transnasal SPG blocks when a predefined threshold is met per the study protocol.",[18],"Combination Product: Transnasal sphenopalatine ganglion block",[20],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"COMBINATION_PRODUCT","Transnasal sphenopalatine ganglion block","Transnasal sphenopalatine ganglion blocks will be performed using the Tx360 device. Medications used during the procedure include 0.75% bupivacaine with or without 1 mg of preservative free dexamethasone.",[14],[26,27],"SPG block","peripheral nerve block",[29],{"name":30,"affiliation":5,"role":31},"Christine Picinich, MS, AGACNP-BC, CCRN","PRINCIPAL_INVESTIGATOR",[33,38],{"name":34,"role":35,"phone":36,"phoneExt":12,"email":37},"Janice Wang-Polagruto, PhD, CCRP","CONTACT","916-551-3244","jfwang@ucdavis.edu",{"name":39,"role":35,"phone":40,"phoneExt":12,"email":41},"Ryan Martin, MD","916-734-4300","rymartin@ucdavis.edu",[43],{"facility":44,"status":45,"city":46,"state":47,"zip":48,"country":49,"countryCode":50,"cosmosGeoPoint":51,"geoPoint":56,"contacts":57},"UC Davis Medical Center","RECRUITING","Sacramento","California","95817","United States","US",{"type":52,"coordinates":53},"Point",[54,55],-121.4944,38.58157,{"lat":55,"lon":54},[58,62,64],{"name":59,"role":35,"phone":60,"phoneExt":12,"email":61},"Christine Picinich, AGACNP-BC, MS","7075368452","cpicinich@ucdavis.edu",{"name":63,"role":35,"phone":12,"phoneExt":12,"email":12},"Christine Picinich",{"name":59,"role":31,"phone":12,"phoneExt":12,"email":12},{"type":66,"investigatorFullName":12,"investigatorTitle":12,"investigatorAffiliation":12,"oldNameTitle":12,"oldOrganization":12},"SPONSOR",[68],{"name":69,"class":70},"Agnes Marshall Walker Foundation","UNKNOWN","100563835","phase-2-transnasal-sphenopalatine-ganglion-block-for-treatment-of-acute-subarachnoid-hemorrhage-associated-headache-100563835",false,"NCT06621329","Transnasal Sphenopalatine Ganglion Block for Treatment of Acute Subarachnoid Hemorrhage Associated Headache","Inclusion Criteria:\n\n* Acute subarachnoid hemorrhage\n* Age greater than 18 years\n* Secured aneurysm\n* Patient can verbalize pain score to clinician, nurse, medical translator, or surrogate decision\n* maker\n* Patient or surrogate decision maker is available to consent\n\nExclusion Criteria:\n\n* Less than 18 years old\n* Unsecured aneurysm\n* Pregnant or lactating\n* Prisoner\n* Unable to verbalize pain score to clinician, nurse, medical translator, or surrogate decision maker\n* Nasal or facial trauma or surgery within the last three months\n* Allergy to lidocaine, bupivacaine, or dexamethasone\n* Patient is unable to consent and no available surrogate decision maker","ALL","18 Years","100 Years",{"count":81,"type":82},40,"ESTIMATED","INTERVENTIONAL",[85,86],"PHASE2","PHASE3","The study titled \\"Transnasal sphenopalatine ganglion block for treatment of acute subarachnoid hemorrhage associated headache\\" is a randomized controlled pilot study aimed at evaluating the efficacy of a transnasal sphenopalatine ganglion (SPG) block in addition to standard pain medication for reducing headache severity in patients with acute subarachnoid hemorrhage (aSAH). The study also examines whether this intervention can reduce opioid requirements during hospitalization and upon discharge.",[89,90],"SAH (Subarachnoid Hemorrhage)","Headache",[92,27,93,94,95],"aSAH","sphenopalatine ganglion","subarachnoid hemorrhage","headache","2025-11-24",{"date":98,"type":99},"2025-11-26","ACTUAL",{"date":101,"type":99},"2024-10-17",{"date":103,"type":82},"2026-10",{"name":5,"class":6},1]